1. Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992;Chang;Cancer,1998
2. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute;Hance;J Natl Cancer Inst,2005
3. Inflammatory breast cancer biology: the tumour microenvironment is key;Lim;Nat Rev Cancer,2018
4. Molecular subtypes in patients with inflammatory breast cancer; a single center experience;Kertmen;J Buon,2015
5. Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in patients (Pts) with HER2+ metastatic breast cancer (mBC): results of the randomized phase III DESTINY-Breast03 study [abstract];Cortés;Ann Oncol,2021